Educational Alliance to Optimize CV risk management

CV Risk Master Classes: Applying new insights to clinical practice

These lectures have been recorded during the CardioVascular Risk Master Class Latin American chapter, held on November 1-2, 2013 in Bogota, Colombia. The presentations are intended for educational support of participants to the meeting. To view and open the presentations an additional log-on with a passcode is required. This passcode is provided to meeting participants only.

Update on new CV risk reduction guidelines: An international perspective

Prof. John Deanfield, MD, University College London, United Kingdom
   

Macrovascular disease in diabetes: Opportunities for lipid management

Prof. John Betteridge, MD, University College London, United Kingdom
   

Update on new CV risk reduction guidelines: An international perspective

Dr. Kees Hovingh, MD, Academic Medical Centre, Amsterdam, the Netherlands
   

The unassailable case for LDL-c lowering & statin therapy

Dr. Kees Hovingh, MD, Academic Medical Centre, Amsterdam, Netherlands
   

How does BP lowering prevent the clinical manifestations of CVD

Prof. Luis Ruilope, MD, Madrid, Spain
   

The kidney & statin therapy: Friend or Foe?

Prof. Raul Santos, MD, Sao Paulo Medical School, Sao Paolo, Brazil
   

The challenge for CV risk management in Latin America

Prof. John Deanfield, MD, UCL, London, United Kingdom